|
RMS Cox PH Model
|
|
51
|
4010
|
November 21, 2024
|
|
Overall survival vs disease-free survival and other surrogate endpoints
|
|
6
|
7769
|
November 5, 2024
|
|
RMS Case Study in Cox Regression
|
|
4
|
16127
|
September 28, 2024
|
|
Dynamic regression for survival analysis
|
|
0
|
362
|
September 18, 2024
|
|
Andersen-Gill - multistate and time varying covariate
|
|
6
|
619
|
August 27, 2024
|
|
Summary table of different Cox PHM models to compare them
|
|
3
|
415
|
August 12, 2024
|
|
C-index with clustered data
|
|
1
|
499
|
August 8, 2024
|
|
Marginal Structural Models
|
|
2
|
464
|
July 25, 2024
|
|
Progression in cancer trials
|
|
26
|
4565
|
June 25, 2024
|
|
External validation of a time-to-event prognostic model
|
|
2
|
807
|
May 2, 2024
|
|
When should Standardized Mean Differences (SMD) be used? If there is a significant difference, is Cox regression or Propensity Score Matching more appropriate?
|
|
1
|
721
|
April 17, 2024
|
|
Numerical Differences in Survival Probability Estimates between coxph and cph Functions
|
|
8
|
1132
|
March 24, 2024
|
|
Validate and calibrate Cox model on dataset with a categorical covariate with few observations
|
|
2
|
887
|
March 21, 2024
|
|
External Validation and Calibration of Cox model
|
|
13
|
6443
|
March 12, 2024
|
|
Retrospective discussion on the ALS drug, RELYVRIO
|
|
0
|
567
|
March 10, 2024
|
|
Is Lithium Equivalent to Lecanemab in Slowing cognitive decline in Alzheimer's Disease?
|
|
0
|
811
|
February 23, 2024
|
|
Time to pre-randomization monthly seizure count
|
|
1
|
684
|
February 8, 2024
|
|
Creating a Nomogram with Multiply Imputed Datasets
|
|
1
|
888
|
January 31, 2024
|
|
Use of cpower function in Hmisc package
|
|
4
|
1159
|
January 9, 2024
|
|
Calculating fraction of new information in Cox proportional hazard models
|
|
17
|
1902
|
December 14, 2023
|
|
Combining HR from same study sub-groups for meta-analysis
|
|
0
|
784
|
November 28, 2023
|
|
Immortal time bias
|
|
2
|
816
|
October 29, 2023
|
|
Interpreting Survival Probability in Relation to 'Number at Risk' and Median Follow-Up Times
|
|
2
|
1115
|
October 3, 2023
|
|
ROC has a S shape, why?
|
|
30
|
4965
|
August 25, 2023
|
|
Time-to-event analysis with a blocking factor
|
|
3
|
922
|
August 14, 2023
|
|
Survival analysis vs. nested case-control analysis
|
|
3
|
1488
|
August 14, 2023
|
|
External validation or a bigger modelling sample?
|
|
9
|
1991
|
August 12, 2023
|
|
RMS Case Study in Parametric Survival Modeling
|
|
0
|
12077
|
September 17, 2021
|
|
Survival curves - categorization vs continuous in cox model
|
|
5
|
1324
|
August 11, 2023
|
|
Case-control study with and corresponding subgroup
|
|
2
|
875
|
July 20, 2023
|